MedPath

Changes of Serum Orphanin FQ in Patients With Coronary Heart Disease in Different Courses of Diabetes Mellitus

Completed
Conditions
Type2 Diabetes
Interventions
Procedure: Coronary angiography
Registration Number
NCT04572802
Lead Sponsor
Second Hospital of Shanxi Medical University
Brief Summary

To explore the severity of diabetic patients with coronary heart disease and the change of serum orphanin FQ content in different diabetic courses

Detailed Description

Methods: A retrospective case-control study was conducted. The control group was a patient who underwent coronary angiography at the same time and was definitely diagnosed as coronary heart disease but not diabetes. The study group was coronary heart disease complicated with diabetes, which was divided into group A (≤5 years), group B (5-10 years) and group C (10-20 years) according to the course of diabetes. (1) Review the electronic medical records and record the general information of the selected patients: age, sex, history of hypertension, history of myocardial infarction, family history of coronary heart disease, smoking history, chronic kidney disease; ② laboratory findings: HbA1C (glycosylated hemoglobin), SBP (systolic blood pressure), DBP (diastolic blood pressure), total cholesterol, HDL, LDL, triglyceride, BMI, creatinine and glomerular passing rate (EGFR); ③ Drug use: oral hypoglycemic agents, insulin, aspirin, statins, hypertension drugs, ACEI or ARB, β-blockers, CCB and diuretics. (ii) Taking coronary angiography as the gold standard, the grading index of severity of coronary heart disease was made, and the severity of coronary heart disease was evaluated by Gensini score.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • The main discharge diagnosis is T2DM;;
  • Age > 18 years old;
  • No acute complications of diabetes;
  • The previous diagnosis was coronary heart disease
Exclusion Criteria
  • T1DM patients;
  • EGFR < 60 ml/min/1.73 m or proteinuria (or both);
  • Patients with history of acute cardiovascular events;
  • Familial hypercholesterolemia or other hereditary lipid metabolism diseases;
  • anti-HIV patients;
  • Patients with serious mental health problems;
  • Patients receiving drugs that can lead to dyslipidemia, such as antipsychotics, corticosteroids, or immunosuppressants;
  • Patients with systemic inflammatory diseases, such as systemic lupus erythematosus; Pet-name ruby is quitting smoking and severe obesity (BMI>40).

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
control groupCoronary angiographyCoronary heart disease population: after coronary angiography, Gensini score was used to evaluate the severity of coronary artery occlusion, and then compared with the population of type 2 diabetes complicated with coronary heart disease
experimental group(course of disease10-20 years)Coronary angiographyType 2 diabetes complicated with coronary heart disease (course of disease 10 -20years).Finally, the data were obtained to evaluate the relationship between the course of diabetes and the severity of coronary heart disease, as well as the relationship between the course of diabetes and OFQ in patients' blood.
experimental group (course of disease <5 years)Coronary angiographyType 2 diabetes complicated with coronary heart disease (course of disease 5-10 years).Retrospective examination of patients' data, recording patients' laboratory tests and drug use, taking blood to measure orphanin, and evaluating the severity of coronary artery occlusion with Gensini score.
experimental group(course of disease 5-10 years)Coronary angiographyType 2 diabetes complicated with coronary heart disease (course of disease 5-10 years).
Primary Outcome Measures
NameTimeMethod
Gensini score1 week

Gensini score was used to evaluate the severity of coronary artery occlusion, and then compared with the population of type 2 diabetes complicated with coronary heart disease

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Second of Shanxi Medical University

🇨🇳

Taiyuan, Shanxi, China

© Copyright 2025. All Rights Reserved by MedPath